Association of PARP-1, NF-κB, NF-κBIA and IL-6, IL-1β and TNF-α with Graves Disease and Graves Ophthalmopathy

Graves Disease (GD) is an autoimmune disorder affected by an interaction of multiple genes such as Nuclear Factor-κB (NF-κB), Nuclear Factor-κB Inhibitor (NF-κBIA), Poly (ADP-ribose) polymerase-1 (PARP-1) and cytokines like Interleukin-1β (IL-1β), Interleukin-6 (IL-6) and Tumor Necrosis Factor-α (TN...

Full description

Saved in:
Bibliographic Details
Published inGene Vol. 547; no. 2; pp. 226 - 232
Main Authors Niyazoglu, Mutlu, Baykara, Onur, Koc, Arzuhan, Aydoğdu, Pinar, Onaran, Ilhan, Dellal, Fatma Dilek, Tasan, Ertuğrul, Sultuybek, Gönül Kanigur
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.09.2014
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Graves Disease (GD) is an autoimmune disorder affected by an interaction of multiple genes such as Nuclear Factor-κB (NF-κB), Nuclear Factor-κB Inhibitor (NF-κBIA), Poly (ADP-ribose) polymerase-1 (PARP-1) and cytokines like Interleukin-1β (IL-1β), Interleukin-6 (IL-6) and Tumor Necrosis Factor-α (TNF-α) and mostly accompanied by an ocular disorder, Graves Ophthalmopathy (GO). We hypothesize that there is a relationship between GD, GO, polymorphisms of inflammatory related genes and their association with cytokines, which may play important roles in autoimmune and inflammatory processes. To confirm our hypothesis, we studied the polymorphisms and cytokine levels of 120 patients with GD and GO using PCR-RFLP and ELISA methods, respectively. We found that patients with GG genotype and carriers of G allele of PARP-1 G1672A polymorphism are at risk in the group having GD (p=0.0007) while having GA genotype may be protective against the disease. PARP-1 C410T polymorphism was found to be associated with GO by increasing the risk by 1.7 times (p=0.004). Another risk factor for development of GO was the polymorphism of del/ins of NFkB1 gene (p=0.032) that increases the risk by 39%. Levels of cytokines were also elevated in patients with GD, but no association was found between levels of cytokines and the development of GO as there was no change in levels of cytokines. We suggest that, PARP-1 and NFkB1 gene polymorphisms may be risk factors for developing Graves Disease and Ophthalmopathy. •Graves Disease is an autoinflammatory disease.•We studied the genetics of Graves Disease and Ophthalmopathy.•G allele carriers of PARP-1 G1672A polymorphism are at risk of having GD.•GA genotype of G1672A polymorphism may be protective against the disease.•Having polymorphism of del/ins in NFkB1 gene may increase the risk of having GO.
AbstractList Graves Disease (GD) is an autoimmune disorder affected by an interaction of multiple genes such as Nuclear Factor-κB (NF-κB), Nuclear Factor-κB Inhibitor (NF-κBIA), Poly (ADP-ribose) polymerase-1 (PARP-1) and cytokines like Interleukin-1β (IL-1β), Interleukin-6 (IL-6) and Tumor Necrosis Factor-α (TNF-α) and mostly accompanied by an ocular disorder, Graves Ophthalmopathy (GO). We hypothesize that there is a relationship between GD, GO, polymorphisms of inflammatory related genes and their association with cytokines, which may play important roles in autoimmune and inflammatory processes. To confirm our hypothesis, we studied the polymorphisms and cytokine levels of 120 patients with GD and GO using PCR-RFLP and ELISA methods, respectively. We found that patients with GG genotype and carriers of G allele of PARP-1 G1672A polymorphism are at risk in the group having GD (p=0.0007) while having GA genotype may be protective against the disease. PARP-1 C410T polymorphism was found to be associated with GO by increasing the risk by 1.7 times (p=0.004). Another risk factor for development of GO was the polymorphism of del/ins of NFkB1 gene (p=0.032) that increases the risk by 39%. Levels of cytokines were also elevated in patients with GD, but no association was found between levels of cytokines and the development of GO as there was no change in levels of cytokines. We suggest that, PARP-1 and NFkB1 gene polymorphisms may be risk factors for developing Graves Disease and Ophthalmopathy.
Background Graves Disease (GD) is an autoimmune disorder affected by an interaction of multiple genes such as Nuclear Factor- Kappa B (NF- Kappa B), Nuclear Factor- Kappa B Inhibitor (NF- Kappa BIA), Poly (ADP-ribose) polymerase-1 (PARP-1) and cytokines like Interleukin-1 beta (IL-1 beta ), Interleukin-6 (IL-6) and Tumor Necrosis Factor- alpha (TNF- alpha ) and mostly accompanied by an ocular disorder, Graves Ophthalmopathy (GO). We hypothesize that there is a relationship between GD, GO, polymorphisms of inflammatory related genes and their association with cytokines, which may play important roles in autoimmune and inflammatory processes. Subjects and methods To confirm our hypothesis, we studied the polymorphisms and cytokine levels of 120 patients with GD and GO using PCR-RFLP and ELISA methods, respectively. Results We found that patients with GG genotype and carriers of G allele of PARP-1 G1672A polymorphism are at risk in the group having GD (p=0.0007) while having GA genotype may be protective against the disease. PARP-1 C410T polymorphism was found to be associated with GO by increasing the risk by 1.7 times (p=0.004). Another risk factor for development of GO was the polymorphism of del/ins of NFkB1 gene (p=0.032) that increases the risk by 39%. Levels of cytokines were also elevated in patients with GD, but no association was found between levels of cytokines and the development of GO as there was no change in levels of cytokines. Conclusions We suggest that, PARP-1 and NFkB1 gene polymorphisms may be risk factors for developing Graves Disease and Ophthalmopathy.
Graves Disease (GD) is an autoimmune disorder affected by an interaction of multiple genes such as Nuclear Factor-κB (NF-κB), Nuclear Factor-κB Inhibitor (NF-κBIA), Poly (ADP-ribose) polymerase-1 (PARP-1) and cytokines like Interleukin-1β (IL-1β), Interleukin-6 (IL-6) and Tumor Necrosis Factor-α (TNF-α) and mostly accompanied by an ocular disorder, Graves Ophthalmopathy (GO). We hypothesize that there is a relationship between GD, GO, polymorphisms of inflammatory related genes and their association with cytokines, which may play important roles in autoimmune and inflammatory processes.To confirm our hypothesis, we studied the polymorphisms and cytokine levels of 120 patients with GD and GO using PCR-RFLP and ELISA methods, respectively.We found that patients with GG genotype and carriers of G allele of PARP-1 G1672A polymorphism are at risk in the group having GD (p=0.0007) while having GA genotype may be protective against the disease. PARP-1 C410T polymorphism was found to be associated with GO by increasing the risk by 1.7 times (p=0.004). Another risk factor for development of GO was the polymorphism of del/ins of NFkB1 gene (p=0.032) that increases the risk by 39%. Levels of cytokines were also elevated in patients with GD, but no association was found between levels of cytokines and the development of GO as there was no change in levels of cytokines.We suggest that, PARP-1 and NFkB1 gene polymorphisms may be risk factors for developing Graves Disease and Ophthalmopathy.
Graves Disease (GD) is an autoimmune disorder affected by an interaction of multiple genes such as Nuclear Factor-κB (NF-κB), Nuclear Factor-κB Inhibitor (NF-κBIA), Poly (ADP-ribose) polymerase-1 (PARP-1) and cytokines like Interleukin-1β (IL-1β), Interleukin-6 (IL-6) and Tumor Necrosis Factor-α (TNF-α) and mostly accompanied by an ocular disorder, Graves Ophthalmopathy (GO). We hypothesize that there is a relationship between GD, GO, polymorphisms of inflammatory related genes and their association with cytokines, which may play important roles in autoimmune and inflammatory processes. To confirm our hypothesis, we studied the polymorphisms and cytokine levels of 120 patients with GD and GO using PCR-RFLP and ELISA methods, respectively. We found that patients with GG genotype and carriers of G allele of PARP-1 G1672A polymorphism are at risk in the group having GD (p=0.0007) while having GA genotype may be protective against the disease. PARP-1 C410T polymorphism was found to be associated with GO by increasing the risk by 1.7 times (p=0.004). Another risk factor for development of GO was the polymorphism of del/ins of NFkB1 gene (p=0.032) that increases the risk by 39%. Levels of cytokines were also elevated in patients with GD, but no association was found between levels of cytokines and the development of GO as there was no change in levels of cytokines. We suggest that, PARP-1 and NFkB1 gene polymorphisms may be risk factors for developing Graves Disease and Ophthalmopathy. •Graves Disease is an autoinflammatory disease.•We studied the genetics of Graves Disease and Ophthalmopathy.•G allele carriers of PARP-1 G1672A polymorphism are at risk of having GD.•GA genotype of G1672A polymorphism may be protective against the disease.•Having polymorphism of del/ins in NFkB1 gene may increase the risk of having GO.
Graves Disease (GD) is an autoimmune disorder affected by an interaction of multiple genes such as Nuclear Factor-κB (NF-κB), Nuclear Factor-κB Inhibitor (NF-κBIA), Poly (ADP-ribose) polymerase-1 (PARP-1) and cytokines like Interleukin-1β (IL-1β), Interleukin-6 (IL-6) and Tumor Necrosis Factor-α (TNF-α) and mostly accompanied by an ocular disorder, Graves Ophthalmopathy (GO). We hypothesize that there is a relationship between GD, GO, polymorphisms of inflammatory related genes and their association with cytokines, which may play important roles in autoimmune and inflammatory processes.BACKGROUNDGraves Disease (GD) is an autoimmune disorder affected by an interaction of multiple genes such as Nuclear Factor-κB (NF-κB), Nuclear Factor-κB Inhibitor (NF-κBIA), Poly (ADP-ribose) polymerase-1 (PARP-1) and cytokines like Interleukin-1β (IL-1β), Interleukin-6 (IL-6) and Tumor Necrosis Factor-α (TNF-α) and mostly accompanied by an ocular disorder, Graves Ophthalmopathy (GO). We hypothesize that there is a relationship between GD, GO, polymorphisms of inflammatory related genes and their association with cytokines, which may play important roles in autoimmune and inflammatory processes.To confirm our hypothesis, we studied the polymorphisms and cytokine levels of 120 patients with GD and GO using PCR-RFLP and ELISA methods, respectively.SUBJECTS AND METHODSTo confirm our hypothesis, we studied the polymorphisms and cytokine levels of 120 patients with GD and GO using PCR-RFLP and ELISA methods, respectively.We found that patients with GG genotype and carriers of G allele of PARP-1 G1672A polymorphism are at risk in the group having GD (p=0.0007) while having GA genotype may be protective against the disease. PARP-1 C410T polymorphism was found to be associated with GO by increasing the risk by 1.7 times (p=0.004). Another risk factor for development of GO was the polymorphism of del/ins of NFkB1 gene (p=0.032) that increases the risk by 39%. Levels of cytokines were also elevated in patients with GD, but no association was found between levels of cytokines and the development of GO as there was no change in levels of cytokines.RESULTSWe found that patients with GG genotype and carriers of G allele of PARP-1 G1672A polymorphism are at risk in the group having GD (p=0.0007) while having GA genotype may be protective against the disease. PARP-1 C410T polymorphism was found to be associated with GO by increasing the risk by 1.7 times (p=0.004). Another risk factor for development of GO was the polymorphism of del/ins of NFkB1 gene (p=0.032) that increases the risk by 39%. Levels of cytokines were also elevated in patients with GD, but no association was found between levels of cytokines and the development of GO as there was no change in levels of cytokines.We suggest that, PARP-1 and NFkB1 gene polymorphisms may be risk factors for developing Graves Disease and Ophthalmopathy.CONCLUSIONSWe suggest that, PARP-1 and NFkB1 gene polymorphisms may be risk factors for developing Graves Disease and Ophthalmopathy.
Author Onaran, Ilhan
Sultuybek, Gönül Kanigur
Aydoğdu, Pinar
Koc, Arzuhan
Niyazoglu, Mutlu
Tasan, Ertuğrul
Dellal, Fatma Dilek
Baykara, Onur
Author_xml – sequence: 1
  givenname: Mutlu
  surname: Niyazoglu
  fullname: Niyazoglu, Mutlu
  email: mutluniyaz@hotmail.com
  organization: Istanbul Training and Research Hospital, Endocrinology Department, Istanbul, Turkey
– sequence: 2
  givenname: Onur
  surname: Baykara
  fullname: Baykara, Onur
  email: obaykara@istanbul.edu.tr
  organization: Istanbul University, Cerrahpasa Medical Faculty, Department of Medical Biology and Genetics, Istanbul, Turkey
– sequence: 3
  givenname: Arzuhan
  orcidid: 0000-0002-4022-1014
  surname: Koc
  fullname: Koc, Arzuhan
  email: akoc87@gmail.com
  organization: Istanbul University, Cerrahpasa Medical Faculty, Department of Medical Biology and Genetics, Istanbul, Turkey
– sequence: 4
  givenname: Pinar
  orcidid: 0000-0003-3038-5119
  surname: Aydoğdu
  fullname: Aydoğdu, Pinar
  email: aydogdupinar@gmail.com
  organization: Istanbul University, Cerrahpasa Medical Faculty, Department of Medical Biology and Genetics, Istanbul, Turkey
– sequence: 5
  givenname: Ilhan
  surname: Onaran
  fullname: Onaran, Ilhan
  email: ilonaran@istanbul.edu.tr
  organization: Istanbul University, Cerrahpasa Medical Faculty, Department of Medical Biology and Genetics, Istanbul, Turkey
– sequence: 6
  givenname: Fatma Dilek
  surname: Dellal
  fullname: Dellal, Fatma Dilek
  email: drdellal@yahoo.com
  organization: Ankara Training and Research Hospital, Endocrinology Department, Ankara, Turkey
– sequence: 7
  givenname: Ertuğrul
  surname: Tasan
  fullname: Tasan, Ertuğrul
  email: etasan@hotmail.com
  organization: Bezmialem Vakif University, Faculty of Medicine, Department of Internal Medicine, Istanbul, Turkey
– sequence: 8
  givenname: Gönül Kanigur
  surname: Sultuybek
  fullname: Sultuybek, Gönül Kanigur
  email: kanigur@istanbul.edu.tr
  organization: Istanbul University, Cerrahpasa Medical Faculty, Department of Medical Biology and Genetics, Istanbul, Turkey
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24956560$$D View this record in MEDLINE/PubMed
BookMark eNqFkc1u3CAUhVGVqpmkfYEuKi-7iB3AgLHUzTTNz0ijJqrSNWLg0mHkMRPwpMpjNcs8RJ4p9vxsukhYcNG937lI5xyhgza0gNBngguCiThdFH-ghYJiwgosClzKd2hEZFXnuH8foBEuK5kTQupDdJTSAveHc_oBHVJWc8EFHqG7cUrBeN350GbBZTfjXzc5Ocl-XuTPT9_3dTLOdGuzyTQXJ8NNnh83jdth_C_767t5dhn1PaTsh0-gE2zGu9b1at7NdbMMK93NHz6i9043CT7t6jH6fXF-e3aVT68vJ2fjaW4YrrrcuopxWVtMnKVGWAvGOg2l1LXAklrHOXdGO2FcOav0bFYyI2tiJNGm4oyWx-jrdu8qhrs1pE4tfTLQNLqFsE6K9m4Qjhnjb6JE0KqWmAr8NspZ_zsjUvTolx26ni3BqlX0Sx0f1N78HpBbwMSQUgSnjO82SXRR-0YRrIac1UINOashZ4WF6rPtpfQ_6X77q6JvWxH0tt97iCoZD60B6yOYTtngX5O_ABLFv7k
CitedBy_id crossref_primary_10_17116_terarkh2015871067_71
crossref_primary_10_1007_s11596_023_2708_7
crossref_primary_10_1111_sji_12471
crossref_primary_10_1016_j_eprac_2020_11_011
crossref_primary_10_1016_j_jns_2015_12_047
crossref_primary_10_1371_journal_pone_0137654
crossref_primary_10_1038_hgv_2014_16
crossref_primary_10_3892_etm_2017_4047
crossref_primary_10_1515_abm_2020_0008
crossref_primary_10_1155_2020_4748612
crossref_primary_10_1038_srep16672
crossref_primary_10_1007_s12031_019_01299_8
crossref_primary_10_1128_MMBR_00038_18
crossref_primary_10_3349_ymj_2017_58_6_1160
crossref_primary_10_3389_fcell_2024_1480950
crossref_primary_10_1007_s00417_021_05456_x
crossref_primary_10_26442_terarkh201890104_39
crossref_primary_10_1016_j_prp_2024_155608
crossref_primary_10_1016_j_intimp_2015_09_004
crossref_primary_10_1016_j_theriogenology_2020_11_022
crossref_primary_10_1007_s12011_015_0455_8
crossref_primary_10_1139_cjpp_2016_0332
crossref_primary_10_5301_ijbm_5000267
crossref_primary_10_1038_s41598_018_20701_w
Cites_doi 10.1074/jbc.M106528200
10.1007/s10875-013-9906-1
10.1530/EJE-09-0600
10.1002/art.10864
10.1530/eje.0.1320668
10.1002/bies.20085
10.1073/pnas.170226797
10.1007/s001090000132
10.1016/S0889-8529(05)70130-4
10.1124/pr.54.3.375
10.1210/jc.2005-1689
10.1016/j.humimm.2010.01.023
10.1046/j.1365-2265.2003.01708.x
10.1101/gad.9.22.2723
10.1007/s10528-009-9302-y
10.17925/EE.2008.04.02.107
10.1038/eye.2009.244
10.1159/000099471
10.1530/eje.0.1430197
10.1046/j.1365-2249.2000.01335.x
10.1093/rheumatology/kei262
10.1371/journal.pone.0052298
10.1136/ard.2007.077040
10.1210/jcem-72-5-1113
10.1006/mgme.2000.3015
10.1016/S0165-6147(98)01193-6
10.1111/j.1742-4658.2005.04864.x
10.1038/nrd1718
10.1186/1471-2350-13-116
10.1016/j.diabres.2007.10.020
10.1007/s00296-008-0772-8
10.1080/07315724.2008.10719741
10.1016/0092-8674(86)90807-X
10.1007/s00018-002-8527-2
10.1007/BF03344951
10.1002/jcla.20379
10.1016/j.jns.2007.02.008
10.1007/BF03346682
10.1016/j.arcmed.2008.09.003
10.1038/sj.gene.6364418
10.1186/1756-6614-2-10
10.1097/MOP.0b013e32832cf824
10.1586/ecp.12.54
ContentType Journal Article
Copyright 2014 Elsevier B.V.
Copyright © 2014 Elsevier B.V. All rights reserved.
Copyright_xml – notice: 2014 Elsevier B.V.
– notice: Copyright © 2014 Elsevier B.V. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
8FD
FR3
P64
RC3
7S9
L.6
DOI 10.1016/j.gene.2014.06.038
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Technology Research Database
Engineering Research Database
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
AGRICOLA
AGRICOLA - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
Genetics Abstracts
Engineering Research Database
Technology Research Database
Biotechnology and BioEngineering Abstracts
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList MEDLINE
Genetics Abstracts
AGRICOLA

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Engineering
Anatomy & Physiology
Biology
EISSN 1879-0038
EndPage 232
ExternalDocumentID 24956560
10_1016_j_gene_2014_06_038
S0378111914007021
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
-~X
.~1
0R~
1B1
1RT
1~.
1~5
4.4
457
4G.
5GY
5VS
7-5
71M
8P~
9JM
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAXUO
ABFNM
ABFRF
ABGSF
ABJNI
ABLJU
ABMAC
ABUDA
ABXDB
ABYKQ
ACDAQ
ACGFO
ACGFS
ACIUM
ACNCT
ACRLP
ADBBV
ADEZE
ADUVX
AEBSH
AEFWE
AEHWI
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
AXJTR
BKOJK
BLXMC
CS3
DOVZS
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
IHE
J1W
KOM
LX3
M41
MO0
N9A
O-L
O9-
OAUVE
OZT
P-8
P-9
P2P
PC.
Q38
RIG
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SPCBC
SSU
SSZ
T5K
WH7
ZA5
~G-
.55
.GJ
29H
53G
AAHBH
AAQXK
AATTM
AAXKI
AAYWO
AAYXX
ABDPE
ABEFU
ABWVN
ACRPL
ACVFH
ADCNI
ADIYS
ADMUD
ADNMO
ADVLN
AEIPS
AEUPX
AFJKZ
AFPUW
AGCQF
AGQPQ
AGRDE
AGRNS
AI.
AIGII
AIIUN
AKBMS
AKRWK
AKYEP
ANKPU
APXCP
ASPBG
AVWKF
AZFZN
BNPGV
CITATION
FEDTE
FGOYB
G-2
HLW
HVGLF
HZ~
MVM
R2-
SBG
SEW
SSH
VH1
WUQ
X7M
XOL
XPP
Y6R
ZGI
~KM
CGR
CUY
CVF
ECM
EIF
NPM
7X8
8FD
FR3
P64
RC3
7S9
L.6
ID FETCH-LOGICAL-c407t-df74589d01fd2c6ddecdfae38a96082df555fcaf6cf3b7abb34c891c81ac75423
IEDL.DBID .~1
ISSN 0378-1119
1879-0038
IngestDate Fri Jul 11 11:02:28 EDT 2025
Fri Jul 11 11:26:45 EDT 2025
Fri Jul 11 03:41:26 EDT 2025
Thu Apr 03 07:04:29 EDT 2025
Tue Jul 01 01:22:47 EDT 2025
Thu Apr 24 22:56:45 EDT 2025
Fri Feb 23 02:23:22 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Graves Disease
Graves Ophthalmopathy
Cytokine
GO
NF-κB1A
PCR-RFLP
GAG
IL-1β
PARP-1
IL-6
NF-κB
NLS
SNP
TNF-α
TRAb
GD
Polymorphism
Language English
License Copyright © 2014 Elsevier B.V. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c407t-df74589d01fd2c6ddecdfae38a96082df555fcaf6cf3b7abb34c891c81ac75423
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-3038-5119
0000-0002-4022-1014
PMID 24956560
PQID 1547544186
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_2000150445
proquest_miscellaneous_1627980260
proquest_miscellaneous_1547544186
pubmed_primary_24956560
crossref_citationtrail_10_1016_j_gene_2014_06_038
crossref_primary_10_1016_j_gene_2014_06_038
elsevier_sciencedirect_doi_10_1016_j_gene_2014_06_038
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-09-01
PublicationDateYYYYMMDD 2014-09-01
PublicationDate_xml – month: 09
  year: 2014
  text: 2014-09-01
  day: 01
PublicationDecade 2010
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Gene
PublicationTitleAlternate Gene
PublicationYear 2014
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Senturk, Kozaci, Kok, Kadikoylu, Bolaman (bb0230) 2003; 26
Huang, Yang, Yao, Wang, Liao, Huang (bb0225) 2008; 39
Kiziltunc, Basoglu, Avci, Capoglu (bb0235) 1999; 29
Infante, Llorca, Mateo, Rodrigues-Rodrigues, Quintana, Juan, Fernández-Viadero, Peña, Berciano, Combarros (bb0065) 2007; 23
Kurylowicz, Mis'kiewicz, Bar-Andziak, Nauman, Bednarczuk (bb0135) 2009; 2
Tsai, Tsai, Lin, Lin, Liu, Liao, Wan (bb0020) 2012; 13
Scerrino, Morfino, Paladino, Di Paola, Amodio, Gulotta, Bonventre (bb0010) 2012
Daroszewski, Pawlak, Karabon, Frydecka, Jonkisz, Slowik, Bolanowski (bb0155) 2009; 161
Yelamos, Olive (bb0050) 2002; 21
Verma, Stevenson, Schwarz, Van Antwerp, Miyamoto (bb0140) 1995; 9
Burch, Bahn (bb0005) 2006; 2
Celik, Akalin, Erbas (bb0105) 1995; 132
Liu, Lin, Wu, Liu, Wang, Tsai (bb0115) 2010; 24
Bartalena, Brogioni, Grasso (bb0080) 1993; 16
Schimke, Rieber, Rylaarsdam, Cabral-Marques, Hubbard, Puel, Kallmann, Sombke, Notheis, Schwarz, Kammer, Hökfelt, Repp, Picard, Casanova, Belohradsky, Albert, Ochs, Renner, Torgerson (bb0145) 2013; 33
Siddiqi, Monson, Wood (bb0095) 1999; 84
Wakelkamp, Bakker, Baldeschi, Wiersinga, Prummel (bb0270) 2003; 58
Infante, Juan, Mateo, Rodriguez-Rodriguez, Sanchez-Quintana, Llorca, Fontalba, Terrazas, Oterino, Berciano, Combarros (bb0075) 2007; 256
Sen, Baltimore (bb0120) 1986; 47
Zhu, Liu, Zhao, Jia, Cui, Ning (bb0160) 2010; 33
Laddha, Dwivedi, Begum (bb0250) 2012; 7
Tuncay, Okyay, Bardakci (bb0125) 2010; 48
Anvar, Khalilzadeh, Esteghamati, Esfahani, Rashidi, Etemadi, Mahmoudi, Amirzargar (bb0170) 2010; 24
Chopra, Sakane, Teco (bb0100) 1991; 72
Heemstra, Smit (bb0025) 2008; 4
Antonelli, Rotondi, Ferrari, Fallahi, Romagnani, Franceschini, Serio, Ferrannini (bb0265) 2006; 91
Salvi, Girasole, Pedrazzoni, Passeri, Giuliani, Minelli, Braverman, Roti (bb0090) 1996; 81
Cottet, Blanche, Verasdonck, Le Galli, Schächter, Bürkle, Muiras (bb0195) 2000; 78
García, Bodaño, Pablos, Gómez-Reino, Conde (bb0180) 2008; 67
Burkle (bb0055) 2005; 272
Onaran, Tezcan, Ozgononel, Cetin, Ozdemir, Kanigur-Sultuybek (bb0070) 2009; 29
Bartalena, Grasso, Brogioni (bb0085) 1994; 78
Comings, MacMurray (bb0210) 2000; 71
Nikitin, Chudakova, Strokov, Bursa, Chistiakov, Nosikov (bb0200) 2008; 79
Shen, Oesterling, Stromberg, Toborek, MacDonald, Hennig (bb0220) 2008; 27
Szabó, Dawson (bb0185) 1998; 19
Al-Humaidi (bb0245) 2000; 21
Zsuzsanna, Zoltan, Camelia, Corina, Anisie, Jozsef (bb0255) 2010
Wakelkamp, Gerding, van der Meer, Bakker, Prummel, Wiersinga (bb0260) 2000; 121
Liu, Li, Liu, Zhao, Cui, Ning (bb0165) 2010; 71
Bahn (bb0015) 2012; 5
Virag, Szabo (bb0040) 2002; 54
Hur, Sung, Shin, Park, Cheong, Bae (bb0205) 2006; 45
Pascual, L'opez-Nevot, C'aliz, Ferrer, Balsa, Pascual-Salcedo, Martin (bb0110) 2003; 48
Hassa, Covic, Hasan, Imhof, Hottiger (bb0190) 2001; 276
Gough (bb0030) 2000; 29-2
Hassa, Hottiger (bb0215) 2002; 59
Ame, Spenlehauer, de Murcia (bb0060) 2004; 26
Salvi, Pedrazzoni, Girasole, Giuliani, Minelli, Wall, Roti (bb0240) 2000; 143
Brown (bb0150) 2009; 21
Kurylowicz, Hiromatsu, Jurecka-lubieniecka, Kula, Kowalska, Ichimura, Koga, Kaku, Bar-Andziak, Nauman, Jarzab, Ploski, Bednarczuk (bb0130) 2007; 8
Liaudet, Soriano, Szabo, Virag, Mabley, Salzman, Szabo (bb0175) 2000; 97
Jagtap, Szabo (bb0045) 2005; 4
Kabalak (bb0035) 2009
Wakelkamp (10.1016/j.gene.2014.06.038_bb0260) 2000; 121
Tsai (10.1016/j.gene.2014.06.038_bb0020) 2012; 13
Pascual (10.1016/j.gene.2014.06.038_bb0110) 2003; 48
Hur (10.1016/j.gene.2014.06.038_bb0205) 2006; 45
Laddha (10.1016/j.gene.2014.06.038_bb0250) 2012; 7
Infante (10.1016/j.gene.2014.06.038_bb0065) 2007; 23
Szabó (10.1016/j.gene.2014.06.038_bb0185) 1998; 19
Kiziltunc (10.1016/j.gene.2014.06.038_bb0235) 1999; 29
Kurylowicz (10.1016/j.gene.2014.06.038_bb0135) 2009; 2
Tuncay (10.1016/j.gene.2014.06.038_bb0125) 2010; 48
Onaran (10.1016/j.gene.2014.06.038_bb0070) 2009; 29
Chopra (10.1016/j.gene.2014.06.038_bb0100) 1991; 72
Hassa (10.1016/j.gene.2014.06.038_bb0215) 2002; 59
Liu (10.1016/j.gene.2014.06.038_bb0165) 2010; 71
Liu (10.1016/j.gene.2014.06.038_bb0115) 2010; 24
Huang (10.1016/j.gene.2014.06.038_bb0225) 2008; 39
Brown (10.1016/j.gene.2014.06.038_bb0150) 2009; 21
Gough (10.1016/j.gene.2014.06.038_bb0030) 2000; 29-2
Al-Humaidi (10.1016/j.gene.2014.06.038_bb0245) 2000; 21
Sen (10.1016/j.gene.2014.06.038_bb0120) 1986; 47
Shen (10.1016/j.gene.2014.06.038_bb0220) 2008; 27
Zsuzsanna (10.1016/j.gene.2014.06.038_bb0255) 2010
Liaudet (10.1016/j.gene.2014.06.038_bb0175) 2000; 97
Daroszewski (10.1016/j.gene.2014.06.038_bb0155) 2009; 161
Anvar (10.1016/j.gene.2014.06.038_bb0170) 2010; 24
Salvi (10.1016/j.gene.2014.06.038_bb0240) 2000; 143
Yelamos (10.1016/j.gene.2014.06.038_bb0050) 2002; 21
Bartalena (10.1016/j.gene.2014.06.038_bb0085) 1994; 78
Heemstra (10.1016/j.gene.2014.06.038_bb0025) 2008; 4
Bartalena (10.1016/j.gene.2014.06.038_bb0080) 1993; 16
Infante (10.1016/j.gene.2014.06.038_bb0075) 2007; 256
Kabalak (10.1016/j.gene.2014.06.038_bb0035) 2009
Salvi (10.1016/j.gene.2014.06.038_bb0090) 1996; 81
Scerrino (10.1016/j.gene.2014.06.038_bb0010) 2012
Virag (10.1016/j.gene.2014.06.038_bb0040) 2002; 54
Verma (10.1016/j.gene.2014.06.038_bb0140) 1995; 9
Senturk (10.1016/j.gene.2014.06.038_bb0230) 2003; 26
Kurylowicz (10.1016/j.gene.2014.06.038_bb0130) 2007; 8
Zhu (10.1016/j.gene.2014.06.038_bb0160) 2010; 33
Burch (10.1016/j.gene.2014.06.038_bb0005) 2006; 2
Siddiqi (10.1016/j.gene.2014.06.038_bb0095) 1999; 84
Cottet (10.1016/j.gene.2014.06.038_bb0195) 2000; 78
Celik (10.1016/j.gene.2014.06.038_bb0105) 1995; 132
Comings (10.1016/j.gene.2014.06.038_bb0210) 2000; 71
Bahn (10.1016/j.gene.2014.06.038_bb0015) 2012; 5
Nikitin (10.1016/j.gene.2014.06.038_bb0200) 2008; 79
Schimke (10.1016/j.gene.2014.06.038_bb0145) 2013; 33
García (10.1016/j.gene.2014.06.038_bb0180) 2008; 67
Ame (10.1016/j.gene.2014.06.038_bb0060) 2004; 26
Burkle (10.1016/j.gene.2014.06.038_bb0055) 2005; 272
Hassa (10.1016/j.gene.2014.06.038_bb0190) 2001; 276
Jagtap (10.1016/j.gene.2014.06.038_bb0045) 2005; 4
Antonelli (10.1016/j.gene.2014.06.038_bb0265) 2006; 91
Wakelkamp (10.1016/j.gene.2014.06.038_bb0270) 2003; 58
References_xml – volume: 16
  start-page: 213
  year: 1993
  end-page: 218
  ident: bb0080
  article-title: Increased serum interleukin-6 concentrations in patients with subacute thyroiditis: relationship with concomitant changes in serum T4-binding globulin concentrations
  publication-title: J. Endocrinol. Inv.
– volume: 23
  start-page: 215
  year: 2007
  end-page: 218
  ident: bb0065
  article-title: Interaction between poly(ADP-Ribose) polymerase 1 and interleukin 1A genes is associated with Alzheimer's disease risk
  publication-title: Dement. Geriatr. Cogn. Disord.
– volume: 24
  start-page: 1058
  year: 2010
  end-page: 1063
  ident: bb0170
  article-title: Genetic susceptibility to Graves' ophthalmopathy: the role of polymorphisms in proinflammatory cytokine genes
  publication-title: Eye (Lond)
– volume: 71
  start-page: 397
  year: 2010
  end-page: 401
  ident: bb0165
  article-title: The association of interleukin-1alpha and interleukin-1beta polymorphisms with the risk of Graves' disease in a case–control study and meta-analysis
  publication-title: Hum. Immunol.
– volume: 21
  start-page: 639
  year: 2000
  end-page: 644
  ident: bb0245
  article-title: Serum cytokines levels in Graves' Disease
  publication-title: Saudi Med. J.
– volume: 13
  start-page: 116
  year: 2012
  ident: bb0020
  article-title: Thymic stromal lymphopoietin gene promoter polymorphisms and expression levels in Graves' disease and Graves' ophthalmopathy
  publication-title: BMC Med. Genet.
– volume: 33
  start-page: 1088
  year: 2013
  end-page: 1099
  ident: bb0145
  article-title: A novel gain-of-function IKBA mutation underlies ectodermal dysplasia with immunodeficiency and polyendocrinopathy
  publication-title: J. Clin. Immunol.
– volume: 29
  start-page: 25
  year: 1999
  end-page: 29
  ident: bb0235
  article-title: Serum IL-6 and TNF-a in patients with thyroid disorders
  publication-title: Tr. J. Med. Sci.
– volume: 48
  start-page: 104
  year: 2010
  end-page: 112
  ident: bb0125
  article-title: Identification of NF-kB1 and NF-kBIA polymorphisms using PCR-RFLP Assay in a Turkish population
  publication-title: Biochem. Genet.
– volume: 48
  start-page: 638
  year: 2003
  end-page: 641
  ident: bb0110
  article-title: A poly(ADP-ribose) polymerase haplotype spanning the promoter region confers susceptibility to rheumatoid arthritis
  publication-title: Arthritis Rheum.
– volume: 26
  start-page: 58
  year: 2003
  end-page: 63
  ident: bb0230
  article-title: Proinflammatory cytokine levels in hyperthyroidism
  publication-title: Clin. Invest. Med.
– volume: 78
  start-page: 423
  year: 1994
  end-page: 427
  ident: bb0085
  article-title: Serum interleukin-6 in amiodarone-induced thyrotoxicosis
  publication-title: J. Clin. Endocrinol. Metab.
– volume: 132
  start-page: 668
  year: 1995
  end-page: 672
  ident: bb0105
  article-title: Serum levels of interleukin (IL)-6 and tumor necrosis factor-α in hyperthyroid patients before and after propylthiouracil treatment
  publication-title: Eur. J. Endocrinol.
– volume: 26
  start-page: 882
  year: 2004
  end-page: 893
  ident: bb0060
  article-title: The PARP superfamily
  publication-title: BioEssays
– volume: 21
  start-page: 523
  year: 2009
  end-page: 528
  ident: bb0150
  article-title: Autoimmune thyroid disease: unlocking a complex puzzle
  publication-title: Curr. Opin. Pediatr.
– volume: 2
  start-page: 2029
  year: 2006
  end-page: 2042
  ident: bb0005
  article-title: Graves ophthalmopathy
  publication-title: Endocrinology
– volume: 58
  start-page: 280
  year: 2003
  end-page: 287
  ident: bb0270
  article-title: TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients
  publication-title: Clin. Endocrinol.
– volume: 24
  start-page: 182
  year: 2010
  end-page: 186
  ident: bb0115
  article-title: Evaluation of the poly(ADP-ribose) polymerase-1 gene variants in Alzheimer's disease
  publication-title: J. Clin. Lab. Ann.
– volume: 7
  start-page: e52298
  year: 2012
  ident: bb0250
  article-title: Increased tumor necrosis factor (TNF)-a and its promoter polymorphisms correlate with disease progression and higher susceptibility towards vitiligo
  publication-title: PLoS One
– volume: 71
  start-page: 19
  year: 2000
  end-page: 31
  ident: bb0210
  article-title: Molecular heterosis: a review
  publication-title: Mol. Genet. Metab.
– volume: 47
  start-page: 921
  year: 1986
  end-page: 928
  ident: bb0120
  article-title: Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappaB by a posttranslational mechanism
  publication-title: Cell
– volume: 81
  start-page: 2976
  year: 1996
  end-page: 2979
  ident: bb0090
  article-title: Increased serum concentrations of interleukin (IL)-6 and soluble IL-6 receptor in patients with Graves' disease
  publication-title: J. Clin. Endocrinol. Metab.
– volume: 67
  start-page: 631
  year: 2008
  end-page: 637
  ident: bb0180
  article-title: Poly(ADP-ribose) polymerase inhibition reduces tumor necrosis factor-induced inflammatory response in rheumatoid synovial fibroblasts
  publication-title: Ann. Rheum. Dis.
– volume: 143
  start-page: 197
  year: 2000
  end-page: 202
  ident: bb0240
  article-title: Serum concentrations of proinflammatory cytokines in Graves' disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking
  publication-title: Eur. J. Endocrinol.
– volume: 19
  start-page: 287
  year: 1998
  end-page: 298
  ident: bb0185
  article-title: Role of poly(ADP-ribose) synthetase in inflammation and ischaemia–reperfusion
  publication-title: Trends Pharmacol. Sci.
– volume: 45
  start-page: 711
  year: 2006
  end-page: 717
  ident: bb0205
  article-title: Poly(ADP-ribose) polymerase (PARP) polymorphisms associated with 58 nephritis and arthritis in systemic lupus erythematosus
  publication-title: Rheumatology (Oxford)
– volume: 21
  start-page: 219
  year: 2002
  end-page: 227
  ident: bb0050
  article-title: Role of poly (ADP-ribose) polymerase-1 (PARP-1) in the inflammatory response
  publication-title: Immunologia
– start-page: 801
  year: 2010
  ident: bb0255
  article-title: Cytokine profile in Graves' ophthalmopathy patients
  publication-title: Endocr. Abstr.
– volume: 29-2
  start-page: 255
  year: 2000
  ident: bb0030
  article-title: The genetic of Graves disease
  publication-title: Endocrinol. Metab. Clin. N. Am.
– volume: 2
  start-page: 10
  year: 2009
  ident: bb0135
  article-title: Association of polymorphism in genes encoding κB inhibitors (IκB) with susceptibility to and phenotype of Graves' disease: a case–control study
  publication-title: Thyroid. Res.
– volume: 91
  start-page: 614
  year: 2006
  end-page: 620
  ident: bb0265
  article-title: Interferon-γ-inducible α-chemokine CXCL10 involvement in Graves' ophthalmopathy: modulation by peroxisome proliferator-activated receptor-γ agonists
  publication-title: J. Clin. Endocrinol. Metab.
– volume: 39
  start-page: 775
  year: 2008
  end-page: 784
  ident: bb0225
  article-title: Activation and overexpression of PARP-1 in circulating mononuclear cells promote TNF-α and IL-6 expression in patients with unstable angina
  publication-title: Arch. Med. Res.
– volume: 8
  start-page: 532
  year: 2007
  end-page: 538
  ident: bb0130
  article-title: Association of NFKB1—94ins/del ATTg promoter polymorphism with susceptibility to and phenotype of Graves's Disease
  publication-title: Genes Immun.
– start-page: 353
  year: 2009
  end-page: 360
  ident: bb0035
  article-title: Tiroid ve Otoimmünite
  publication-title: Tiroid El Kitabı
– volume: 79
  start-page: 446
  year: 2008
  end-page: 452
  ident: bb0200
  article-title: Leu54Phe and Val762Ala polymorphisms in the poly(ADP-ribose)polymerase-1 gene are associated with diabetic polyneuropathy in Russian type 1 diabetic patients
  publication-title: Diabetes Res. Clin. Pract.
– year: 2012
  ident: bb0010
  article-title: Does thyroid surgery for Graves' disease improve health-related quality of life?
  publication-title: Surg. Today
– volume: 5
  start-page: 605
  year: 2012
  end-page: 660
  ident: bb0015
  article-title: Emerging pharmacotherapy for treatment of Graves' disease
  publication-title: Expert. Rev. Clin. Pharmacol.
– volume: 59
  start-page: 1534
  year: 2002
  end-page: 1553
  ident: bb0215
  article-title: The functional role of poly(ADP-ribose)polymerase 1 as novel coactivator of NFк-B in inflammatory disorders
  publication-title: Cell. Mol. Life Sci.
– volume: 84
  start-page: 435
  year: 1999
  end-page: 439
  ident: bb0095
  article-title: Serum cytokines in thyrotoxicosis
  publication-title: J. Clin. Endocrinol. Metab.
– volume: 33
  start-page: 751
  year: 2010
  end-page: 755
  ident: bb0160
  article-title: Association analysis of polymorphisms in IL-3, IL-4, IL-5, IL-9, and IL-13 with Graves' disease
  publication-title: J. Endocrinol. Invest.
– volume: 97
  start-page: 10203
  year: 2000
  end-page: 10208
  ident: bb0175
  article-title: Protection against hemorrhagic shock in mice genetically deficient in poly(ADP-ribose) polymerase
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
– volume: 78
  start-page: 471
  year: 2000
  end-page: 480
  ident: bb0195
  article-title: New polymorphisms in the human poly (ADP-ribose) polymerase-1 coding sequence: lack of association with longevity or with increased cellular poly (ADP-ribosyl)ation capacity
  publication-title: J. Mol. Med.
– volume: 4
  start-page: 421
  year: 2005
  end-page: 440
  ident: bb0045
  article-title: Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors
  publication-title: Nat. Rev. Drug Discov.
– volume: 256
  start-page: 68
  year: 2007
  end-page: 70
  ident: bb0075
  article-title: Poly (ADP-ribose) polymerase-1 (PARP-1) genetic variants are protective against Parkinson's disease
  publication-title: J. Neurol. Sci.
– volume: 276
  start-page: 45588
  year: 2001
  end-page: 45597
  ident: bb0190
  article-title: The enzymatic and DNA binding activity of PARP-1 are not required for NF-kB coactivator function
  publication-title: J. Biol. Chem.
– volume: 29
  start-page: 797
  year: 2009
  end-page: 800
  ident: bb0070
  article-title: The Val762Ala polymorphism in the poly(ADP-ribose) polymerase-1 gene is not associated with susceptibility in Turkish rheumatoid arthritis patients
  publication-title: Rheumatol. Int.
– volume: 72
  start-page: 1113
  year: 1991
  end-page: 1116
  ident: bb0100
  article-title: A study of the serum concentration of tumor necrosis factor-α in thyroidal and nonthyroidal illnesses
  publication-title: J. Clin. Endocrinol. Metab.
– volume: 4
  start-page: 107
  year: 2008
  end-page: 109
  ident: bb0025
  article-title: Advances in the treatment of Graves' disease—a focus on Rituximab
  publication-title: Eur. Endocrinol.
– volume: 54
  start-page: 375
  year: 2002
  end-page: 429
  ident: bb0040
  article-title: The therapeutic potential of poly(ADP-ribose) polymerase inhibitors
  publication-title: Pharmacol. Rev.
– volume: 9
  start-page: 2723
  year: 1995
  end-page: 2735
  ident: bb0140
  article-title: Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation
  publication-title: Genes Dev.
– volume: 272
  start-page: 4576
  year: 2005
  end-page: 4589
  ident: bb0055
  article-title: Poly (ADP-ribose). The most elaborate metabolite of NAD
  publication-title: Febs J.
– volume: 27
  start-page: 577
  year: 2008
  end-page: 587
  ident: bb0220
  article-title: Zinc deficiency induces vascular pro-inflammatory parameters associated with NF-kappa B and PPAR signaling
  publication-title: J. Am. Coll. Nutr.
– volume: 161
  start-page: 787
  year: 2009
  end-page: 793
  ident: bb0155
  article-title: Soluble CTLA-4 receptor an immunological marker of Graves' disease and severity of ophthalmopathy is associated with CTLA-4 Jo31 and CT60 gene polymorphisms
  publication-title: Eur. J. Endocrinol.
– volume: 121
  start-page: 453
  year: 2000
  end-page: 457
  ident: bb0260
  article-title: Both Th1 and Th2 derived cytokines in serum are elevated in Graves' ophthalmopathy
  publication-title: Clin. Exp. Immunol.
– volume: 276
  start-page: 45588
  year: 2001
  ident: 10.1016/j.gene.2014.06.038_bb0190
  article-title: The enzymatic and DNA binding activity of PARP-1 are not required for NF-kB coactivator function
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M106528200
– volume: 33
  start-page: 1088
  year: 2013
  ident: 10.1016/j.gene.2014.06.038_bb0145
  article-title: A novel gain-of-function IKBA mutation underlies ectodermal dysplasia with immunodeficiency and polyendocrinopathy
  publication-title: J. Clin. Immunol.
  doi: 10.1007/s10875-013-9906-1
– volume: 161
  start-page: 787
  year: 2009
  ident: 10.1016/j.gene.2014.06.038_bb0155
  article-title: Soluble CTLA-4 receptor an immunological marker of Graves' disease and severity of ophthalmopathy is associated with CTLA-4 Jo31 and CT60 gene polymorphisms
  publication-title: Eur. J. Endocrinol.
  doi: 10.1530/EJE-09-0600
– volume: 48
  start-page: 638
  issue: 3
  year: 2003
  ident: 10.1016/j.gene.2014.06.038_bb0110
  article-title: A poly(ADP-ribose) polymerase haplotype spanning the promoter region confers susceptibility to rheumatoid arthritis
  publication-title: Arthritis Rheum.
  doi: 10.1002/art.10864
– volume: 132
  start-page: 668
  year: 1995
  ident: 10.1016/j.gene.2014.06.038_bb0105
  article-title: Serum levels of interleukin (IL)-6 and tumor necrosis factor-α in hyperthyroid patients before and after propylthiouracil treatment
  publication-title: Eur. J. Endocrinol.
  doi: 10.1530/eje.0.1320668
– volume: 26
  start-page: 882
  year: 2004
  ident: 10.1016/j.gene.2014.06.038_bb0060
  article-title: The PARP superfamily
  publication-title: BioEssays
  doi: 10.1002/bies.20085
– volume: 21
  start-page: 219
  issue: 4
  year: 2002
  ident: 10.1016/j.gene.2014.06.038_bb0050
  article-title: Role of poly (ADP-ribose) polymerase-1 (PARP-1) in the inflammatory response
  publication-title: Immunologia
– volume: 97
  start-page: 10203
  year: 2000
  ident: 10.1016/j.gene.2014.06.038_bb0175
  article-title: Protection against hemorrhagic shock in mice genetically deficient in poly(ADP-ribose) polymerase
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
  doi: 10.1073/pnas.170226797
– volume: 78
  start-page: 471
  year: 2000
  ident: 10.1016/j.gene.2014.06.038_bb0195
  article-title: New polymorphisms in the human poly (ADP-ribose) polymerase-1 coding sequence: lack of association with longevity or with increased cellular poly (ADP-ribosyl)ation capacity
  publication-title: J. Mol. Med.
  doi: 10.1007/s001090000132
– volume: 29-2
  start-page: 255
  year: 2000
  ident: 10.1016/j.gene.2014.06.038_bb0030
  article-title: The genetic of Graves disease
  publication-title: Endocrinol. Metab. Clin. N. Am.
  doi: 10.1016/S0889-8529(05)70130-4
– volume: 54
  start-page: 375
  year: 2002
  ident: 10.1016/j.gene.2014.06.038_bb0040
  article-title: The therapeutic potential of poly(ADP-ribose) polymerase inhibitors
  publication-title: Pharmacol. Rev.
  doi: 10.1124/pr.54.3.375
– volume: 91
  start-page: 614
  issue: 2
  year: 2006
  ident: 10.1016/j.gene.2014.06.038_bb0265
  article-title: Interferon-γ-inducible α-chemokine CXCL10 involvement in Graves' ophthalmopathy: modulation by peroxisome proliferator-activated receptor-γ agonists
  publication-title: J. Clin. Endocrinol. Metab.
  doi: 10.1210/jc.2005-1689
– start-page: 353
  year: 2009
  ident: 10.1016/j.gene.2014.06.038_bb0035
  article-title: Tiroid ve Otoimmünite
– volume: 71
  start-page: 397
  issue: 4
  year: 2010
  ident: 10.1016/j.gene.2014.06.038_bb0165
  article-title: The association of interleukin-1alpha and interleukin-1beta polymorphisms with the risk of Graves' disease in a case–control study and meta-analysis
  publication-title: Hum. Immunol.
  doi: 10.1016/j.humimm.2010.01.023
– volume: 58
  start-page: 280
  issue: 3
  year: 2003
  ident: 10.1016/j.gene.2014.06.038_bb0270
  article-title: TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients
  publication-title: Clin. Endocrinol.
  doi: 10.1046/j.1365-2265.2003.01708.x
– volume: 9
  start-page: 2723
  issue: 22
  year: 1995
  ident: 10.1016/j.gene.2014.06.038_bb0140
  article-title: Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation
  publication-title: Genes Dev.
  doi: 10.1101/gad.9.22.2723
– volume: 48
  start-page: 104
  year: 2010
  ident: 10.1016/j.gene.2014.06.038_bb0125
  article-title: Identification of NF-kB1 and NF-kBIA polymorphisms using PCR-RFLP Assay in a Turkish population
  publication-title: Biochem. Genet.
  doi: 10.1007/s10528-009-9302-y
– volume: 4
  start-page: 107
  issue: 2
  year: 2008
  ident: 10.1016/j.gene.2014.06.038_bb0025
  article-title: Advances in the treatment of Graves' disease—a focus on Rituximab
  publication-title: Eur. Endocrinol.
  doi: 10.17925/EE.2008.04.02.107
– volume: 24
  start-page: 1058
  issue: 6
  year: 2010
  ident: 10.1016/j.gene.2014.06.038_bb0170
  article-title: Genetic susceptibility to Graves' ophthalmopathy: the role of polymorphisms in proinflammatory cytokine genes
  publication-title: Eye (Lond)
  doi: 10.1038/eye.2009.244
– volume: 23
  start-page: 215
  year: 2007
  ident: 10.1016/j.gene.2014.06.038_bb0065
  article-title: Interaction between poly(ADP-Ribose) polymerase 1 and interleukin 1A genes is associated with Alzheimer's disease risk
  publication-title: Dement. Geriatr. Cogn. Disord.
  doi: 10.1159/000099471
– volume: 81
  start-page: 2976
  year: 1996
  ident: 10.1016/j.gene.2014.06.038_bb0090
  article-title: Increased serum concentrations of interleukin (IL)-6 and soluble IL-6 receptor in patients with Graves' disease
  publication-title: J. Clin. Endocrinol. Metab.
– volume: 143
  start-page: 197
  year: 2000
  ident: 10.1016/j.gene.2014.06.038_bb0240
  article-title: Serum concentrations of proinflammatory cytokines in Graves' disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking
  publication-title: Eur. J. Endocrinol.
  doi: 10.1530/eje.0.1430197
– start-page: 801
  issue: 22
  year: 2010
  ident: 10.1016/j.gene.2014.06.038_bb0255
  article-title: Cytokine profile in Graves' ophthalmopathy patients
  publication-title: Endocr. Abstr.
– volume: 121
  start-page: 453
  year: 2000
  ident: 10.1016/j.gene.2014.06.038_bb0260
  article-title: Both Th1 and Th2 derived cytokines in serum are elevated in Graves' ophthalmopathy
  publication-title: Clin. Exp. Immunol.
  doi: 10.1046/j.1365-2249.2000.01335.x
– volume: 45
  start-page: 711
  issue: 6
  year: 2006
  ident: 10.1016/j.gene.2014.06.038_bb0205
  article-title: Poly(ADP-ribose) polymerase (PARP) polymorphisms associated with 58 nephritis and arthritis in systemic lupus erythematosus
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/kei262
– volume: 7
  start-page: e52298
  issue: 12
  year: 2012
  ident: 10.1016/j.gene.2014.06.038_bb0250
  article-title: Increased tumor necrosis factor (TNF)-a and its promoter polymorphisms correlate with disease progression and higher susceptibility towards vitiligo
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0052298
– volume: 67
  start-page: 631
  year: 2008
  ident: 10.1016/j.gene.2014.06.038_bb0180
  article-title: Poly(ADP-ribose) polymerase inhibition reduces tumor necrosis factor-induced inflammatory response in rheumatoid synovial fibroblasts
  publication-title: Ann. Rheum. Dis.
  doi: 10.1136/ard.2007.077040
– volume: 2
  start-page: 2029
  year: 2006
  ident: 10.1016/j.gene.2014.06.038_bb0005
  article-title: Graves ophthalmopathy
– volume: 72
  start-page: 1113
  year: 1991
  ident: 10.1016/j.gene.2014.06.038_bb0100
  article-title: A study of the serum concentration of tumor necrosis factor-α in thyroidal and nonthyroidal illnesses
  publication-title: J. Clin. Endocrinol. Metab.
  doi: 10.1210/jcem-72-5-1113
– volume: 71
  start-page: 19
  year: 2000
  ident: 10.1016/j.gene.2014.06.038_bb0210
  article-title: Molecular heterosis: a review
  publication-title: Mol. Genet. Metab.
  doi: 10.1006/mgme.2000.3015
– volume: 19
  start-page: 287
  year: 1998
  ident: 10.1016/j.gene.2014.06.038_bb0185
  article-title: Role of poly(ADP-ribose) synthetase in inflammation and ischaemia–reperfusion
  publication-title: Trends Pharmacol. Sci.
  doi: 10.1016/S0165-6147(98)01193-6
– volume: 84
  start-page: 435
  year: 1999
  ident: 10.1016/j.gene.2014.06.038_bb0095
  article-title: Serum cytokines in thyrotoxicosis
  publication-title: J. Clin. Endocrinol. Metab.
– volume: 272
  start-page: 4576
  issue: 18
  year: 2005
  ident: 10.1016/j.gene.2014.06.038_bb0055
  article-title: Poly (ADP-ribose). The most elaborate metabolite of NAD+
  publication-title: Febs J.
  doi: 10.1111/j.1742-4658.2005.04864.x
– volume: 21
  start-page: 639
  issue: 7
  year: 2000
  ident: 10.1016/j.gene.2014.06.038_bb0245
  article-title: Serum cytokines levels in Graves' Disease
  publication-title: Saudi Med. J.
– volume: 4
  start-page: 421
  year: 2005
  ident: 10.1016/j.gene.2014.06.038_bb0045
  article-title: Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/nrd1718
– volume: 13
  start-page: 116
  year: 2012
  ident: 10.1016/j.gene.2014.06.038_bb0020
  article-title: Thymic stromal lymphopoietin gene promoter polymorphisms and expression levels in Graves' disease and Graves' ophthalmopathy
  publication-title: BMC Med. Genet.
  doi: 10.1186/1471-2350-13-116
– volume: 79
  start-page: 446
  issue: 3
  year: 2008
  ident: 10.1016/j.gene.2014.06.038_bb0200
  article-title: Leu54Phe and Val762Ala polymorphisms in the poly(ADP-ribose)polymerase-1 gene are associated with diabetic polyneuropathy in Russian type 1 diabetic patients
  publication-title: Diabetes Res. Clin. Pract.
  doi: 10.1016/j.diabres.2007.10.020
– volume: 29
  start-page: 797
  year: 2009
  ident: 10.1016/j.gene.2014.06.038_bb0070
  article-title: The Val762Ala polymorphism in the poly(ADP-ribose) polymerase-1 gene is not associated with susceptibility in Turkish rheumatoid arthritis patients
  publication-title: Rheumatol. Int.
  doi: 10.1007/s00296-008-0772-8
– volume: 27
  start-page: 577
  issue: 5
  year: 2008
  ident: 10.1016/j.gene.2014.06.038_bb0220
  article-title: Zinc deficiency induces vascular pro-inflammatory parameters associated with NF-kappa B and PPAR signaling
  publication-title: J. Am. Coll. Nutr.
  doi: 10.1080/07315724.2008.10719741
– volume: 26
  start-page: 58
  issue: 2
  year: 2003
  ident: 10.1016/j.gene.2014.06.038_bb0230
  article-title: Proinflammatory cytokine levels in hyperthyroidism
  publication-title: Clin. Invest. Med.
– volume: 47
  start-page: 921
  issue: 6
  year: 1986
  ident: 10.1016/j.gene.2014.06.038_bb0120
  article-title: Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappaB by a posttranslational mechanism
  publication-title: Cell
  doi: 10.1016/0092-8674(86)90807-X
– volume: 59
  start-page: 1534
  year: 2002
  ident: 10.1016/j.gene.2014.06.038_bb0215
  article-title: The functional role of poly(ADP-ribose)polymerase 1 as novel coactivator of NFк-B in inflammatory disorders
  publication-title: Cell. Mol. Life Sci.
  doi: 10.1007/s00018-002-8527-2
– volume: 16
  start-page: 213
  year: 1993
  ident: 10.1016/j.gene.2014.06.038_bb0080
  article-title: Increased serum interleukin-6 concentrations in patients with subacute thyroiditis: relationship with concomitant changes in serum T4-binding globulin concentrations
  publication-title: J. Endocrinol. Inv.
  doi: 10.1007/BF03344951
– year: 2012
  ident: 10.1016/j.gene.2014.06.038_bb0010
  article-title: Does thyroid surgery for Graves' disease improve health-related quality of life?
  publication-title: Surg. Today
– volume: 24
  start-page: 182
  issue: 3
  year: 2010
  ident: 10.1016/j.gene.2014.06.038_bb0115
  article-title: Evaluation of the poly(ADP-ribose) polymerase-1 gene variants in Alzheimer's disease
  publication-title: J. Clin. Lab. Ann.
  doi: 10.1002/jcla.20379
– volume: 256
  start-page: 68
  year: 2007
  ident: 10.1016/j.gene.2014.06.038_bb0075
  article-title: Poly (ADP-ribose) polymerase-1 (PARP-1) genetic variants are protective against Parkinson's disease
  publication-title: J. Neurol. Sci.
  doi: 10.1016/j.jns.2007.02.008
– volume: 33
  start-page: 751
  issue: 10
  year: 2010
  ident: 10.1016/j.gene.2014.06.038_bb0160
  article-title: Association analysis of polymorphisms in IL-3, IL-4, IL-5, IL-9, and IL-13 with Graves' disease
  publication-title: J. Endocrinol. Invest.
  doi: 10.1007/BF03346682
– volume: 39
  start-page: 775
  issue: 8
  year: 2008
  ident: 10.1016/j.gene.2014.06.038_bb0225
  article-title: Activation and overexpression of PARP-1 in circulating mononuclear cells promote TNF-α and IL-6 expression in patients with unstable angina
  publication-title: Arch. Med. Res.
  doi: 10.1016/j.arcmed.2008.09.003
– volume: 8
  start-page: 532
  issue: 7
  year: 2007
  ident: 10.1016/j.gene.2014.06.038_bb0130
  article-title: Association of NFKB1—94ins/del ATTg promoter polymorphism with susceptibility to and phenotype of Graves's Disease
  publication-title: Genes Immun.
  doi: 10.1038/sj.gene.6364418
– volume: 2
  start-page: 10
  year: 2009
  ident: 10.1016/j.gene.2014.06.038_bb0135
  article-title: Association of polymorphism in genes encoding κB inhibitors (IκB) with susceptibility to and phenotype of Graves' disease: a case–control study
  publication-title: Thyroid. Res.
  doi: 10.1186/1756-6614-2-10
– volume: 21
  start-page: 523
  year: 2009
  ident: 10.1016/j.gene.2014.06.038_bb0150
  article-title: Autoimmune thyroid disease: unlocking a complex puzzle
  publication-title: Curr. Opin. Pediatr.
  doi: 10.1097/MOP.0b013e32832cf824
– volume: 5
  start-page: 605
  issue: 6
  year: 2012
  ident: 10.1016/j.gene.2014.06.038_bb0015
  article-title: Emerging pharmacotherapy for treatment of Graves' disease
  publication-title: Expert. Rev. Clin. Pharmacol.
  doi: 10.1586/ecp.12.54
– volume: 29
  start-page: 25
  year: 1999
  ident: 10.1016/j.gene.2014.06.038_bb0235
  article-title: Serum IL-6 and TNF-a in patients with thyroid disorders
  publication-title: Tr. J. Med. Sci.
– volume: 78
  start-page: 423
  year: 1994
  ident: 10.1016/j.gene.2014.06.038_bb0085
  article-title: Serum interleukin-6 in amiodarone-induced thyrotoxicosis
  publication-title: J. Clin. Endocrinol. Metab.
SSID ssj0000552
Score 2.3040977
Snippet Graves Disease (GD) is an autoimmune disorder affected by an interaction of multiple genes such as Nuclear Factor-κB (NF-κB), Nuclear Factor-κB Inhibitor...
Background Graves Disease (GD) is an autoimmune disorder affected by an interaction of multiple genes such as Nuclear Factor- Kappa B (NF- Kappa B), Nuclear...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 226
SubjectTerms Adolescent
Adult
Aged
Alleles
Case-Control Studies
Cytokine
enzyme-linked immunosorbent assay
Female
Genetic Association Studies
genotype
Graves Disease
Graves Ophthalmopathy
Graves Ophthalmopathy - genetics
Heterozygote
Humans
I-kappa B Proteins - genetics
INDEL Mutation
interleukin-1beta
Interleukin-1beta - genetics
interleukin-6
Interleukin-6 - genetics
Male
Middle Aged
Mutation, Missense
NF-kappa B - genetics
NF-KappaB Inhibitor alpha
PARP-1
patients
Poly (ADP-Ribose) Polymerase-1
Poly(ADP-ribose) Polymerases - genetics
polymerase chain reaction
Polymorphism
Polymorphism, Single Nucleotide
restriction fragment length polymorphism
risk factors
transcription factor NF-kappa B
tumor necrosis factor-alpha
Tumor Necrosis Factor-alpha - genetics
Title Association of PARP-1, NF-κB, NF-κBIA and IL-6, IL-1β and TNF-α with Graves Disease and Graves Ophthalmopathy
URI https://dx.doi.org/10.1016/j.gene.2014.06.038
https://www.ncbi.nlm.nih.gov/pubmed/24956560
https://www.proquest.com/docview/1547544186
https://www.proquest.com/docview/1627980260
https://www.proquest.com/docview/2000150445
Volume 547
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NThsxELYQCKk9VBTaEqDIlapeipt41944x4U2JG2VohYkbpZ_BRVsAoQDF94Jjn0Inqkee5dSqeTQy_7YY8nr8Y5n7JlvEHprlMsyQx3h2mrClKJEB8WEOFvYoBDkzie0z1ExOGCfD_nhHNppYmHArbKW_UmmR2ldl7Tr0WxPjo_bPzo5REkCPhlg1sRgcsa6MMs_XP9x8-hwnk4SwFoK1HXgTPLxCjwCqEzKIoYnxKj8e3F6TPmMi1B_CT2rtUdcpg4-R3OuWkYrZRUs59Mr_A5Hf864Ub6MFrebp6cPQAdX0NkDjuCxx3vl9z1Ct_CoT-5-bTf3YYlVZfHwKym24ErvbmPBPlTfYNi-xbuQuugCf0xnPLG6Lvo2OZoeqZPTMSQ8vnqBDvqf9ncGpE68QEyw76bE-i7jomc71NvMFEECGuuVy4UK9o7IrOece6N8YXyuu0rrnBnRo0ZQZSCjbv4SzVfjyq0i7IPGUZge044JlmmnvYVUFEx5mxtrdQvRZsSlqVHJITnGiWzcz35K4JIELknwwctFC72_bzNJmBwzqXnDSPnXzJJh0ZjZ7k3DdRl-OThHUZUbX17IoHUCbCAVxQyaIuv2BAC2PU6TxUD2DmO8hV6laXX_PZASHHCR1v6z9-voCbwlb7gNND89v3Svg_o01Zvx_9hEC-Xwy2D0G4D2GT8
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxELaqVAg4IGh5BCgYCXGhVuJde-Mct4-Q0BAqSKXeLD_VonYTaHroz4IjP6K_qZ61txSJ5sBldzW2Ja_HHs_YM98g9NYol2WGOsK11YQpRYkOiglxtrBBIcidj2ifk2J4wD4e8sMVtN3EwoBbZZL9UabX0jpROmk0O_Pj487Xbg5RkoBPBpg1EEy-CuhUvIVWy9HecPJHIHMeLxPAYAoNUuxMdPMKbAK0TMpqGE8IU_n3_nSb_lnvQ4OH6EFSIHEZ-_gIrbhqDa2XVTCeTy_wO1y7dNZn5Wvozlbzdf8G7uA6-n6DKXjm8X75ZZ_QTTwZkMvfW817VGJVWTwak2ITnvTyV02YQvFPDCe4-ANkLzrDO_Gapy5OpM_zo8WROjmdQc7ji8foYLA73R6SlHuBmGDiLYj1PcZF33apt5kpghA01iuXCxVMHpFZzzn3RvnC-Fz3lNY5M6JPjaDKQFLd_AlqVbPKPUPYB6WjMH2mHRMs0057C9komPI2N9bqNqLNiEuTgMkhP8aJbDzQvkngkgQuSXDDy0Ubvb9uM4-wHEtr84aR8q_JJcO-sbTdm4brMqw6uEpRlZudn0kKEy1okqJYUqfIen0BmG2318nqWPYuY7yNnsZpdf0_kBUcoJGe_2fvX6O7w-mnsRyPJnsv0D0oic5xL1Fr8ePcbQRtaqFfpdVyBRYSG_A
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+of+PARP-1%2C+NF-%CE%BAB%2C+NF-%CE%BABIA+and+IL-6%2C+IL-1%CE%B2+and+TNF-%CE%B1+with+Graves+Disease+and+Graves+Ophthalmopathy&rft.jtitle=Gene&rft.au=Niyazoglu%2C+Mutlu&rft.au=Baykara%2C+Onur&rft.au=Koc%2C+Arzuhan&rft.au=Aydo%C4%9Fdu%2C+Pinar&rft.date=2014-09-01&rft.pub=Elsevier+B.V&rft.issn=0378-1119&rft.eissn=1879-0038&rft.volume=547&rft.issue=2&rft.spage=226&rft.epage=232&rft_id=info:doi/10.1016%2Fj.gene.2014.06.038&rft.externalDocID=S0378111914007021
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0378-1119&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0378-1119&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0378-1119&client=summon